Vaccines that induce an antitumour immune response are disappointingly ineffective in treating patients with cancer. Pre-conditioning the vaccination site to induce inflammation might provide a way to improve this therapy. See Letter p.366
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Experimental & Molecular Medicine Open Access 04 January 2024
-
Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis
Journal of Nanobiotechnology Open Access 15 February 2022
-
Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells
Acta Pharmacologica Sinica Open Access 28 May 2020
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Sabado, R. L. & Bhardwaj, N. Ann. NY Acad. Sci. 1284, 31–45 (2013).
Mitchell, D. A. et al. Nature 519, 366–369 (2015).
Palucka, K. & Banchereau, J. Immunity 39, 38–48 (2013).
Kantoff, P. W. et al. N. Engl. J. Med. 363, 411–422 (2010).
Allan, R. S. et al. Immunity 25, 153–162 (2006).
de Vries, I. J. M. et al. Cancer Res. 63, 12–17 (2003).
Martín-Fontecha, A. et al. J. Exp. Med. 198, 615–621 (2003).
Sallusto, F. & Lanzavecchia, A. Immunol Rev. 177, 134–140 (2000).
Griffith, J. W., Sokol, C. L. & Luster, A. D. Annu. Rev. Immunol. 32, 659–702 (2014).
Luther, S. A. & Cyster, J. G. Nature Immunol. 2, 102–107 (2001).
Menten, P., Wuyts, A. & Van Damme, J. Cytokine Growth Factor Rev. 13, 455–481 (2002).
Morlacchi, S. et al. J. Immunol. 186, 6807–6814 (2011).
Nair, S. K., Sampson, J. H. & Mitchell, D. A. OncoImmunology 3, e29289 (2014).
Ridolfi, L. et al. J. Transl. Med. 11, 135 (2013).
Bogunovic, D. et al. Cancer Res. 71, 5467–5476 (2011).
Ribas, A. et al. Clin. Cancer Res. 15, 6267–6276 (2009).
Vera, M. et al. Mol. Ther. 12, 950–959 (2005).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sabado, R., Bhardwaj, N. Dendritic-cell vaccines on the move. Nature 519, 300–301 (2015). https://doi.org/10.1038/nature14211
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14211
This article is cited by
-
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Experimental & Molecular Medicine (2024)
-
Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis
Journal of Nanobiotechnology (2022)
-
Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells
Acta Pharmacologica Sinica (2020)
-
IL33 activates CD8+T and NK cells through MyD88 pathway to suppress the lung cancer cell growth in mice
Biotechnology Letters (2020)
-
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Cancer Immunology, Immunotherapy (2020)